The development and evaluation of an artificial intelligence (AI) image recognition device to improve cervical pre-cancer screening and management in low- and middle-income countries

2020 ◽  
Author(s):  
Partha Basu ◽  
Partha Basu
2017 ◽  
Vol 3 (5) ◽  
pp. 490-496 ◽  
Author(s):  
Olalekan Olasehinde ◽  
Carla Boutin-Foster ◽  
Olusegun I. Alatise ◽  
Adewale O. Adisa ◽  
Oladejo O. Lawal ◽  
...  

Purpose In low- and middle-income countries like Nigeria, women present with advanced breast cancer at an earlier age. Given the limited resources, development of screening programs that parallel resource capabilities of low- and middle-income countries is imperative. The objective of this study was to evaluate the perceptions, practices, and barriers regarding clinical breast examination (CBE) screening in a low-income community in Nigeria. Materials and Methods A cross-sectional survey of women age 40 years or older in Ife, Nigeria, using multistaged sampling was performed. Information on sociodemographics, knowledge of breast cancer, screening practices, and willingness to participate in CBE screening was obtained using an interviewer-administered questionnaire. Results A total of 1,169 women whose ages ranged from 40 to 86 years (mean age, 47.7 years; standard deviation, 8.79 years) were interviewed. The majority of women (94%) knew about breast cancer, whereas 27.5% knew someone who had had breast cancer, the majority of whom (64.5%) had died of the disease. Of the 36% of women who had breast screening recommended to them, only 19.7% had an actual CBE. Of these, only 6% had it in the last year. The majority of women (65.4%) were willing to have regular CBEs and did not care about the sex of the examiner in most instances. Lack of perceived need was the reason cited by women unwilling to participate. Conclusion The majority of women were aware of breast cancer and knew it as a fatal disease. With the relatively encouraging number of those willing to be examined, a carefully designed CBE program coupled with advocacy to correct uneducated beliefs seems promising.


2016 ◽  
Vol 7 ◽  
pp. 4-11 ◽  
Author(s):  
Sujha Subramanian ◽  
Rengaswamy Sankaranarayanan ◽  
Pulikkottil Okkuru Esmy ◽  
Jissa Vinoda Thulaseedharan ◽  
Rajaraman Swaminathan ◽  
...  

Nature Cancer ◽  
2020 ◽  
Vol 1 (12) ◽  
pp. 1140-1152
Author(s):  
Eduardo Edelman Saul ◽  
Raquel B. Guerra ◽  
Michelle Edelman Saul ◽  
Laercio Lopes da Silva ◽  
Gabriel F. P. Aleixo ◽  
...  

2015 ◽  
Vol 62 (5) ◽  
pp. 1324-1332 ◽  
Author(s):  
Robert Caprara ◽  
Keith L. Obstein ◽  
Gabriel Scozzarro ◽  
Christian Di Natali ◽  
Marco Beccani ◽  
...  

2016 ◽  
Vol 2 (1) ◽  
pp. 4-8 ◽  
Author(s):  
Lily A. Gutnik ◽  
Beatrice Matanje-Mwagomba ◽  
Vanessa Msosa ◽  
Suzgo Mzumara ◽  
Blandina Khondowe ◽  
...  

2019 ◽  
Vol 61 (4, jul-ago) ◽  
pp. 542
Author(s):  
Martin Lajous ◽  
Matthew R Cooperberg ◽  
Jennifer Rider ◽  
Hugo Arturo Manzanilla-García ◽  
Fernando Bernardo Gabilondo-Navarro ◽  
...  

 Prostate-specific antigen (PSA)-based early detection for prostate cancer is the subject of intense debate. Imple­mentation of organized prostate cancer screening has been challenging, in part because the PSA test is so amenable to opportunistic screening. To the extent that access to cancer screening tests increases in low- and middle-income countries (LMICs), there is an urgent need to thoughtfully evaluate existing and future cancer screening strategies to ensure benefit and control costs. We used Mexico’s prostate cancer screening efforts to illustrate the challenges LMICs face. We provide five considerations for policymakers for a smarter approach and implementation of PSA-based screening. 


Sign in / Sign up

Export Citation Format

Share Document